Dr. Barbara Kreppel from the magazine “Angewandte Nuklearmedizin” interviewed Prof. Gunther Hartmann, director of the Institute of Clinical Chemistry and Clinical Pharmacology and founding speaker of the ImmunoSensation2 Cluster of Excellence, on his expertise on immunology and nuclear medicine.
During the interview, Prof. Gunther Hartmann shed light on emerging trends in the research fields of immune-oncology and autoimmunity, emphasizing the potential of nuclear medicine for the development of diagnostic tools and novel therapies. He gave an interesting perspective on how nuclear medicine advancements could help with cancer therapy and highlighted the importance of nuclear medicine for immune imaging.
The full interview can be found in the latest issue of “Angewandte Nuklearmedizin”.
Interview:
Angewandte Nuklearmedizin 2024; 47: 78–79
DOI 10.1055/a-2183-2133
ISSN 2749-7445
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG, Rüdigerstraße 14,
70469 Stuttgart, Germany
Press contact:
Dr. Barbara Kreppel
Universitätsklinikum Bonn
Klinik und Poliklinik für Nuklearmedizin
Venusberg-Campus 1
53127 Bonn
E-Mail: barbara.kreppel@ukbonn.de